An assessment of the diets of 38,022 women has concluded that higher fish consumption is associated with reduced risk of age-related macular degeneration (AMD) by as much as 42%.
An assessment of the diets of 38,022 women has concluded that higher fish consumption is associated with reduced risk of age-related macular degeneration (AMD) by as much as 42%. The population study was funded by the National Institutes of Health and will be published in the June issue of Archives of Ophthalmology.
Food frequency questionnaires were provided by 38,022 women with no history of age-related macular degeneration who participated in the Women’s Health Study, a historical human clinical trial assessing the effect aspirin and/or vitamin E on cardiovascular health.
Intake of omega-3 DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) was assessed in each subject through fish consumption rates. Follow-up questionnaires to track incidence of AMD were conducted over ten years.
During follow-up, 235 cases of AMD were reported. Subjects in the highest tertile of DHA intake, compared with those in the lowest tertile, demonstrated a 38% reduced risk of developing AMD. Comparable results were associated with highest consumption of EPA and both omega-3s.
Researchers further concluded that subjects who consumed at least one serving of fish per week showed a 42% reduced risk of AMD compared with subjects who consumed less than one serving of fish per month.
“This lower risk appeared to be due primarily to consumption of canned tuna fish and dark-meat fish,” the authors wrote.
Full text is currently available online for this population study on age-related macular degeneration and fish/omega-3 intake.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.